Table 2. Lung function impairment at diagnosis and outcome of occupational asthma
First author [ref.]Main conclusionSIGN gradeStudy typeExposure/
occupation
Subjects n
Merget [10]No relationship (NSBHR)2-Cohort studyPlatinum salts275
Tarlo [11]+ (NSBHR, FEV1, FVC)3Descriptive study of registerIsocyanates235
Cote [12]+ (SIC), no relationship (FEV1, FVC, NSBHR)2+LongitudinalPlicatic acid (Western red cedar)48
Sorgdrager [13]+ (FEV1)2-LongitudinalFluorides122
Pisati [14]No relationship (FEV1, VC, NSBHR)2-LongitudinalTDI25
Perfetti [15]+ (NSBHR, FEV1)2-LongitudinalVarious HMW and LMW agents99
Park [16]+ (NSBHR)2-LongitudinalTDI35
Chang-Yeung [17]+ (NSBHR, FEV1,FVC)2-LongitudinalWestern red cedar125
Maghni [8]+ (NSBHR)2+LongitudinalVarious HMW and LMW agents133
Lozewicz [18]+ (NSBHR, FEV1)2+LongitudinalIsocyanates (TDI, MDI)56
Hudson [19]+ (FEV1)2-LongitudinalCrab; various HMW and LMW agents63
Malo [20]+ (NSBHR, FEV1)2+LongitudinalVarious HMW and LMW agents80
Park [21]+ (NSBHR)2-LongitudinalTDI41
Mapp [22]+ (SIC), no relationship (FEV1, NSBHR)2-LongitudinalTDI35
Labreque [23]+ (NSBHR, FEV1)2-LongitudinalIsocyanates79
Padoan [9]+ (NSBHR, FEV1)2++LongitudinalTDI87
Soyseth [24]- (Higher NSBHR at baseline favours good prognosis), no relationship (FEV1)2+LongitudinalFluorides38
Moscato [25]+ (FEV1)2+LongitudinalVarious29
  • SIGN: Scottish Intercollegiate Guidelines Network; NSBHR: nonspecific bronchial hyperresponsiveness; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; SIC: specific inhalation challenge; VC: vital capacity; TDI: toluene diisocyanate; HMW: high molecular weight; LMW: low molecular weight; MDI: methylene diphenyl diisocyanate. +: relationship between worse lung function at baseline (FEV1, FVC, VC, NSBHR and SIC) and worse asthma status at follow-up; - : relationship between worse lung function at baseline (FEV1, FVC, VC, NSBHR and SIC) and better asthma status at follow-up.